Using an experimental medicine model to understand the antidepressant potential of the N -Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
There is growing interest in the role of the glutamatergic system both in depression and as a novel target for treatments. Preclinical studies suggested that the non-competitive N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine might have antidepressant properties, but a randomised controlled trial failed to support this. A healthy volunteer model of emotional processing was used to assess the neuropsychological profile of action of memantine. Healthy volunteers ( n=32) were randomised to receive a single dose of memantine (10 mg) or placebo, and subsequently completed a battery of tasks measuring emotional processing, including facial expression recognition, emotional memory, dot-probe and emotion-potentiated startle tasks, as well as working and verbal memory. Memantine treated volunteers showed an increased emotion-potentiated startle, and a reduced bias for negative items in emotional recognition memory. There were no effects of the drug on any other aspect of emotional or non-emotional information processing. These results suggest that a single dose of memantine produces an early anxiogenic response in the emotion-potentiated startle similar to that seen following a single dose of the selective serotonin reuptake inhibitor, citalopram. However, the overall profile of effects is more limited than that which might be expected in response to a conventional antidepressant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, it also failed to affect emotional processing (facial emotion recognition and attentional vigilance to emotional words) and indeed potentiated the startle response (Sani et al. 2012, Pringle et al., 2012).”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Pringle et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 53 · Cited by 21
Research works printed but not linked: 6
- Feusner JD, 2009, Psychopharmacol Bull, 42, 81
- First MB, 1996, Structured Clinical Interview for Axis I and II DSM-IV Disorders: Patient Edition (SCID-IV/P)
- Nelson HE, 1982, National Adult Reading Test (NART): Test Manual
- Rey A, 1964, L’examen de clinique en psychologie
- Skuza G, 2003, Pol J Pharmacol, 55, 1149
- Spielberger CD, 1970, STAI Manual
Metadata
- Authors
- Pringle, A., Parsons, E., Cowen, L., McTavish, S., Cowen, P., & Harmer, C.
- Affiliations
- University of Oxford (GB)
- Department of Psychiatry, University of Oxford, Oxford, UK
- Corresponding author
- Pringle, A
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2012-05-16
- Volume
- 26
- Issue
- 11
- Pages
- 1417-1423
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC3546643
- OpenAlex
- W2115893285
- Cited by
- 21
- References
- 53
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2015: 4 · 2014: 2 · 2013: 2
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Medical Research Council (G0801432, G0801432/1)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- memantine, antidepressant potential, NMDA receptor antagonists, glutamatergic system, depression, anxiogenic effects, emotional memory, facial expression recognition, dot-probe task, working memory, citalopram, healthy volunteers
- MeSH terms
- Adolescent, Adult, Antidepressive Agents, Double-Blind Method, Emotions, Humans, Male, Memantine, Memory, Short-Term, Neuropsychological Tests, Reflex, Startle, Citalopram, Receptors, N-Methyl-D-Aspartate, Selective Serotonin Reuptake Inhibitors, Excitatory Amino Acid Antagonists, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Using an experimental medicine model to understand the antidepressant potential of the N -Methyl-D-aspartic acid (NMDA) receptor antagonist memantine. https://app.cochat.ai/papers/10.1177/0269881112446535
- The paper
- Pringle, A., Parsons, E., Cowen, L., McTavish, S., Cowen, P., & Harmer, C. (2012). Using an experimental medicine model to understand the antidepressant potential of the N -Methyl-D-aspartic acid (NMDA) receptor antagonist memantine. Journal of Psychopharmacology. https://doi.org/10.1177/0269881112446535
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.